dry eye

Why meibography can be a game-changer in treating dry eye
Why meibography can be a game-changer in treating dry eyeDry eye disease (DED) has been historically underserved. Leslie E. O’Dell, OD, FAAO, summarizes what equipment is available today to help you begin evaluating your dry eye patients’ glands.
Helping patients through the dry eye season
Helping patients through the dry eye seasonDr. Tracy Schroeder-Swartz explains the “dry eye season” and how to help patients affected by it.
Using precision medicine for dry eyeThe Precision Medicine Initiative offers a model to customize treatment for each individual patient. Katherine M. Mastrota, MS, OD, FAAO, Dipl ABO explains why using precision medicine to treat dry eye disease can be beneficial for the OD and patient.
3 things you need to know about TFOS DEWS II
3 things you need to know about TFOS DEWS IIIf you have skimmed a few summary articles and are thinking, “Dry eye not really changed much for me,” we’re highlighting the biggest takeaways from TFOS DEWS II that will make you rethink what you think you know about dry eye treatment in our podcast with Drs. Jennifer Craig, Lyndon Jones, and James Wolffsohn.
Can cannabis succeed where other compounds have failedUse of a novel semi-fluorinated alkane drug delivery technology as a vehicle to deliver cannabinoids to the ocular surface reached target tissues without systemic side effects in preclinical studies.
Opportunities and challenges in the world of ophthalmology in 2018As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
Tear osmolarity: Dry eye's 'vital sign'Hyperosmolarity emerges as key mechanism in TFOS DEWS II pathophysiology report
Biologic products increase dry eye optionsMany new diagnostic tools are available for dry eye and ocular surface disease (OSD). Treatments for dry eye and OSD have mixed results, however, said Bennie H. Jeng, MD.
TFOS DEWS II report introduces new patient classification schemeJ. Daniel Nelson, MD, chair of The Tear Film and Ocular Surface Society Dry Eye Workshop II, highlights a new scheme for patient classification.
Four ocular surface health questions to consider before cataract surgeryA thorough investigation of ocular surface health and initiation of any necessary treatment is the first step toward successful cataract surgery.